日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single-cell transcriptomic profiling of immune landscape in triple-negative breast cancer during neoadjuvant chemotherapy

新辅助化疗期间三阴性乳腺癌免疫图谱的单细胞转录组分析

Patysheva, M R; Iamshchikov, P S; Fedorenko, A A; Bragina, O D; Vostrikova, M A; Garbukov, E Y; Cherdyntseva, N V; Denisov, E V; Gerashchenko, T S

Characterization of EpCAM-Positive and EpCAM-Negative Tumor Cells in Early-Stage Breast Cancer

早期乳腺癌中EpCAM阳性和EpCAM阴性肿瘤细胞的特征分析

Perelmuter, Vladimir M; Grigoryeva, Evgeniya S; Alifanov, Vladimir V; Kalinchuk, Anna Yu; Andryuhova, Elena S; Savelieva, Olga E; Patskan, Ivan A; Bragina, Olga D; Garbukov, Evgeniy Yu; Vostrikova, Mariya A; Zavyalova, Marina V; Denisov, Evgeny V; Cherdyntseva, Nadezhda V; Tashireva, Liubov A

EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients

EpCAM-CD24+循环细胞与乳腺癌患者预后不良相关

Perelmuter, V M; Grigoryeva, E S; Savelieva, O E; Alifanov, V V; Andruhova, E S; Zavyalova, M V; Bragina, O D; Garbukov, E Yu; Menyailo, M E; Khozyainova, A A; Denisov, E V; Cherdyntseva, N V; Tashireva, L A

Phase I clinical evaluation of (99m)Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer

99mTc标记的Affibody分子用于乳腺癌HER2表达成像的I期临床评估

Bragina, Olga; Chernov, Vladimir; Larkina, Mariia; Rybina, Anstasiya; Zelchan, Roman; Garbukov, Eugeniy; Oroujeni, Maryam; Loftenius, Annika; Orlova, Anna; Sörensen, Jens; Frejd, Fredrik Y; Tolmachev, Vladimir

DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease

乳腺肿瘤中DNA拷贝数异常和ABC转运蛋白基因表达:与新辅助化疗效果和疾病预后的相关性

Tsyganov, Matvey M; Ibragimova, Marina K; Gaptulbarova, Kseniya A; Tsydenova, Irina A; Dolgasheva, Daria S; Garbukov, Evgeniy Y; Frolova, Anastasia A; Slonimskaya, Elena M; Litvyakov, Nikolai V

Determination of BRCAness Phenotype in Breast Tumors for the Appointment of Neoadjuvant Chemotherapy Based on Platinum and Taxanes

基于铂类和紫杉烷类药物的新辅助化疗方案选择中,乳腺肿瘤BRCA表型的确定

Tsyganov, Matvey Mihajlovich; Ibragimova, Marina K; Garbukov, Evgeniy Y; Bragina, Olga D; Karchevskaya, Ariana A; Usynin, Evgeny A; Litvyakov, Nikolai V

Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer

CTC 中的分子亚型转换作为与乳腺癌无转移生存期相关的治疗充分性的指标

E S Grigoryeva, L A Tashireva, V V Alifanov, O E Savelieva, S V Vtorushin, M V Zavyalova, O D Bragina, E Y Garbukov, N V Cherdyntseva, E L Choinzonov, V M Perelmuter

Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of ERCC1, RRM1, TOP1, TOP2A, TUBB3, TYMS, and GSTP1 Genes in Patients with Breast Cancer

乳腺癌患者 ERCC1、RRM1、TOP1、TOP2A、TUBB3、TYMS 和 GSTP1 基因 mRNA 表达和 DNA 拷贝畸变的预测和预后意义

Matvey M Tsyganov, Marina K Ibragimova, Evgeniy Yu Garbukov, Irina A Tsydenova, Kseniya A Gaptulbarova, Daria S Dolgasheva, Ekaterina A Zdereva, Anastasia A Frolova, Elena M Slonimskaya, Nikolai V Litviakov

Amplifications of Stemness Gene Loci-New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study

干细胞基因位点扩增——确定乳腺癌患者是否需要新辅助化疗的新标记。一项前瞻性研究

Nikolai V Litviakov, Marina K Ibragimova, Matvey M Tsyganov, Polina V Kazantseva, Artem V Doroshenko, Eugeniy Yu Garbukov, Irina G Frolova, Elena M Slonimskaya

Amplifications of stemness genes and the capacity of breast tumors for metastasis

干细胞基因的扩增与乳腺肿瘤的转移能力

Nikolai Litviakov, Marina Ibragimova, Matvey Tsyganov, Polina Kazantseva, Irina Deryusheva, Alina Pevzner, Artem Doroshenko, Eugeny Garbukov, Natalia Tarabanovskaya, Elena Slonimskaya